In Vitro Induction of MUC-1 Peptide-Specific Type 1 T Lymphocyte and Cytotoxic T Lymphocyte Responses from Healthy Multiparous Donors

Journal of Immunology

Volumn 157, Issue 5, 1996, Pages 2089-2095

  Agrawal, Babita ^a,b   Reddish, Mark A ^b   Longenecker, B Michael ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Biomira Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CA 15-3 ANTIGEN; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 4; PEPTIDE;

AMINO ACID SEQUENCE; ANTIGEN PRESENTING CELL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL SURVIVAL; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; PARITY; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

AMINO ACID SEQUENCE; ANTIGEN-PRESENTING CELLS; CA-15-3 ANTIGEN; CELL SURVIVAL; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PARITY; PEPTIDES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030239830     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Hanisch, F.-G., G. Uhlenbruck, J. Peter-Katalinic, H. Egge, J. Dabrowski, and U. Dabrowski. 1989. Structure of O-linked polylactosaminoglycans on human skim milk mucins: a novel type of linearly extended poly-N-acetyl-lactosamine backbones with Galβ(1-4) GlcNAcβ(1-6) repeating units. J. Biol. Chem. 265: 872.
2. Parry, G., J. C. Beck, L. Moss, J. Bartley, and G. K. Ojakian. 1990. Determination of apical membrane polarity in mammary epithelial cell cultures: the role of cell-cell, cell-substratum, and membrane-cytoskeleton interactions. Exp. Cell Rfs. 188:302.
3. Zotter, S., P. C. Hageman, A. Lossnitzer, W. J. Mooi, and J. Hiljers. 1988. Tissue and tumor distribution of human polymorphic epithelial mucin. Cancer Rev. 11: 55.
4. McGuckin, M. A., M. D. Walsh, and B. G. Ward. 1994. Effects of oestrogen and progesterone on production and secretion of MUC-1 mucin by breast cancer cell lines. In Proceedings of the Third International Workshop on Carcinoma-Associated Mucins, p. B.12.
5. Gendler, S., J. Taylor-Papadimitriou, T. Duhig, J. Rothbard, and J. A. Burchell. 1988. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J. Biol. Chem. 263: 12820.
6. Siddiqui, J., M. Abe, D. Hayes, E. Shani, E. Yunis, and D. W. Kufe. 1988. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc. Natl. Acad. Sci. USA 85:2320.
7. Hull, S. R., A. Bright, K. L. Carraway, M. Abe, D. F. Hayes, and D. W. Kufe. 1989. Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. Cancer Commun. 1:261.
8. Burchell, J., S. Gendler, J. Taylor-Papadimitriou, A. Girling, A. Lewis, R. Millis, and D. Lamport. 1987. Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res. 47:5476.
9. Barnd, D. L., M. Lan, R. Metzgar, and O. J. Finn. 1989. Specific, MHC-unrestricted recognition of tumor associated mucins by human cytotoxic T cells. Proc. Natl. Acad. Sci. USA 86:7159.
10. Jerome, K. R., N. Doménech, and O. J. Finn. 1993. Tumor-specific cytotoxic T lymphocyte clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin cDNA. J. Immunol. 151:1654.
11. Finn, O. J. 1992. Antigen-specific, MHC-unrestricted T cells. Biotherapy 4:239.
12. Jerome, K. R., D. L. Barnd, K. M. Bendt, C. M. Boyer, J. Taylor-Papadimitriou, I. F. C. McKenzie, R. C. Bast, Jr., and O. J. Finn. 1991. Cytotoxic T lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res. 51:2908.
13. Doménech, N., R. A. Henderson, and O. J. Finn. 1995. Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin. J. Immunol. 155:4766.
14. Agrawal, B., M. A. Reddish, M. J. Krantz, and B. M. Longenecker. 1995. Does pregnancy immunize against breast cancer? Cancer Res. 55:2257.
15. Visscren, M. J. W., A. V. Elsas, E. I. H. vander Voort, M. E. Ressing, W. M. Kast, P. I. Schrier, and C. J. M. Melief. 1995. CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells. J. Immunol. 154:3991.
16. Apostolopoulos, V., P.-X. Xing, and I. F. C. McKenzie. 1994. Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens. Cancer Res. 54:5186.
17. Townsend, A., and H. Bodmer. 1989. Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 7:601.
18. Cornette, J. L., H. Margalit, C. DeLisi, and J. A. Berzofsky. 1989. Identification of T cell epitopes and use in construction of synthetic vaccines. Methods Enzymol. 178:611.
19. Unanue, E. R., and P. M. Allen. 1987. The basis for the immunoregulatory role of macrophages and other accessory cells. Science 236:551.
20. 2-microgobulin leads to the accumulation of a substantial pool of inactive class I MHC heavy chains on the cell surface. Cell 65:611.
21. 2-microgobulin is required for antigenic peptide binding to isolated class I major histocompatibility complex molecules. Eur. J. Immunol. 21:2289.
22. Ljunggren, H. G., N. J. Stam, J. J. Neefjes, P. Hoglund, M.-T. Heemels, J. Bastin, T. N. M. Schumacher, A. Townsend, K. Kerre, and H. L. Ploegh. 1990. Empty MHC class I molecules come out in cold. Nature 343:476.
23. Mehrotra, P. T., A. J. Grant, and J. P. Siegel. 1995. Synergistic effects of IL-7 and IL-12 on human T cell activation. J. Immunol. 154:5093.
24. Siegel, J. P. 1988. Effects of interferon-γ on the activation of human T lymphocytes. Cell. Immunol. 111:461.
25. Gately, M. K., R. R. Warrier, S. Honasoge, D. M. Carvajal, D. A. Faherty, E. S. Connaughton, T. D. Anderson, U. Sarmiento, B. R. Hubbard, and M. Murohy. 1994. Administration of recombinant IL-12 to normal mice enhances cytolyeic lymphocyte activity and induces production of IFN-yγ. Int. Immunol. 6:157.
26. Nastala, C. L., H. D. Edington, T. G. McKinney, H. Tahara, M. A. Nalesnik, M. J. Brunda, M. K. Gately, S. F. Wolf, R. D. Schreiber, W. J. Storkus, and M. T. Lotze. 1994. Recombinant IL-2 administration induces tumor regression in association with IFN-γ production. J. Immunol. 153:1697.
27. Faber, C., G. Sandt, P. T. Dang, G. Matge, F. Schiltz, and P. Henschling. 1994. Interleukin-4 affects phenotype and proliferative response of peripheral blood lymphocytes from glioblastoma patients after specific or nonspecific in vitro stimulation. J. Immunother. 15:113.
28. Kawakami, Y., S. A. Rosenberg, and M. T. Lotze. 1988. Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma. J. Exp. Med 168:2183.
29. Parronchi, P., M. De Carli, R. Manetti, C. Simonelli, S. Sampognaro, M.-P. Piccinni, D. Macchia, E. Maggi, G. Del Prete, and S. Romagnani. 1992. IL-4 and IFN (α and γ) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J. Immunol. 149:2977.
30. Longenecker, B. M., and G. D. MacLean. 1993. Prospects for mucin epitopes in cancer vaccines. Immunologist 1:89.
31. Ding, L., E.-N. Lalani, M. Reddish, R. Koganty, T. Wong, J. Samuel, M. B. Yacyshyn, A. Meikle, P. Y. S. Fung, J. Taylor-Papadimitriou, and B. M. Longenecker. 1993. Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene. Cancer Immunol. Immunother. 36:9.